Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system

Pharmaceutical Research

Volumn 26, Issue 11, 2009, Pages 2454-2463

  Ameri, Mahmoud ^a   Daddona, Peter E ^a   Maa, Yuh Fun ^a  

^a Zosano Pharma Inc   (United States)

Author keywords

Aggregation; Drug coating; Formulation compatibility; Internal vapor analysis; Oxidation; Parathyroid hormone; PTH(1 34); Transdermal microprojection delivery system

Indexed keywords

FORMALDEHYDE; OXYGEN; PARATHYROID HORMONE[1-34];

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG OXIDATION; DRUG SCREENING; DRUG STABILITY; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION INHIBITION;

ADMINISTRATION, CUTANEOUS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; FEMALE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OXIDATION-REDUCTION; PARATHYROID HORMONE; SURFACE PROPERTIES; WATER;

EID: 70350231749     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9960-9     Document Type: Article

References (22)

1. MR McClung J San Martin PD Miller R Civitelli F Bandeira M Omizo, et al. 2005 Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass Arch Intern Med 165 1762 1768 10.1001/archinte.165.15.1762 1:CAS:528:DC%2BD2MXpslGgs7c%3D 16087825 (Pubitemid 41138965)
2. TM Keaveny PE Hoffman DL Kepperdahl DW Donely K Krohn EV Glass, et al. 2007 Comparison of the effects of teriparatide and alendronate on parameters of total hip strength assessed by finite element analysis (Abstract) J Bone Miner Res 22 Suppl 1 S75
3. TM Keaveny PF Hoffmann M Singh L Palermo JP Bilezikian SL Greenspan, et al. 2008 Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans J Bone Miner Res 12 1974 1982 10.1359/jbmr.080805
4. KG Saag E Shane S Boonen F Marin DW Donely KA Taylor, et al. 2007 Teriparatide or alendronate in glucocorticoid-induced osteoporosis N Engl J Med 357 2028 2039 10.1056/NEJMoa071408 1:CAS:528:DC%2BD2sXhtlWis7rP 18003959 (Pubitemid 350106710)
5. L Fraenkel B Gulanski D Wittink 2006 Patient treatment preferences for osteoporosis Arthritis Rheum 5 729 735 10.1002/art.22229 (Pubitemid 44619186)
6. L Fraenkel B Gulanski D Wittink 2007 Patient willingness to take teriparatide Patient Educ Couns 65 2 237 244 10.1016/j.pec.2006.08.004 16965888 (Pubitemid 46073565)
7. JS Finkelstein A Hayes JL Hunzelman JJ Wyland H Lee RM Neer 2003 The effects of parathyroid hormone. Alendronate, or both in men with osteoporosis N Engl J Med 349 13 1216 1227 10.1056/NEJMoa035725 1:CAS:528:DC%2BD3sXns1Kmsrs%3D 14500805 (Pubitemid 37152031)
8. V Gopalakrishnan S Hwang H Loughrey 2004 Administration of ThPTH to humans using Macroflux® transdermal technology results in the rapid delivery of biologically active PTH. (Abstract) J Bone Miner Res 19 Suppl 1 S460
9. Lane LE, Cosman F, Bolognese M, Zanchetta J, Sees K, Gaumer K, et al. Transdermal delivery of (hPTH 1-34) (ZP-PTH) is effective in increasing bone mineral density of the lumbar spine & hip in postmenopausal women with osteoporosis. (Abstract) Arthritis Rheum. 2008;58(9) late-breaking supplement p.1
10. M Cormier B Johnson M Ameri K Nyam L Libiran DD Zhang, et al. 2004 Transdermal delivery of desmopressin using a coated microneedle array patch system J Controlled Rel 97 503 511 1:CAS:528:DC%2BD2cXkvF2itLs%3D
11. G Widera J Johnson L Kim L Libiran K Nyam PE Daddona, et al. 2006 Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system Vaccine 24 1653 1664 10.1016/j.vaccine.2005.09.049 1:CAS:528:DC%2BD28XhsF2gsr4%3D 16246466 (Pubitemid 43238242)
12. J Matriano M Cormier J Johnson WA Young M Buttery K Nyam, et al. 2002 Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization Pharm Res 19 63 70 10.1023/A:1013607400040 1:CAS:528:DC%2BD38XhtVSmsbg%3D 11837701 (Pubitemid 34075108)
13. WQ Lin M Cormier A Samiee A Griffin B Johnson CL Teng, et al. 2001 Transdermal delivery of oligonucleotides with microprojection patch (Macroflux®) technology Pharm Res 18 1789 1793 10.1023/A:1013395102049 1:CAS:528:DC%2BD38XhvVamsQ%3D%3D 11785702 (Pubitemid 34020438)
14. ER Proos JH Prescott MA Staples 2008 Long-term stability and in vitro release of hPTH(1-34) from a multi-reservoir array Pharm Res 25 6 1387 1395 10.1007/s11095-008-9544-0 1:CAS:528:DC%2BD1cXltFCjsLY%3D 18266089
15. Cormier M, Neukermans AP, Block B, Theeuwes FT, Amkraut A. A device for enhancing transdermal agent delivery or sampling. EP0914178B1. 2003.
16. Trautman JC, Wright CT, Cormier M. Method and apparatus for coating skin piercing microneedles. US Patent 6,855,372 (2002).
17. Trautman JC, Wright CT, Cormier M. Method and apparatus for coating skin piercing microneedles. US Patent 7,435,299 (2002).
18. Y Nabuchi E Fujiwara H Kuboniwa Y Asoh H Ushio 1997 The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues Pharm Res 14 1685 1690 10.1023/A:1012115426306 1:CAS:528: DyaK1cXktFKjtA%3D%3D 9453054 (Pubitemid 28062911)
19. MC Manning K Patel RT Borchardt 1989 Stability of protein pharmaceuticals Pharm Res 6 903 917 10.1023/A:1015929109894 1:CAS:528:DyaK3cXkt1aruw%3D%3D 2687836
20. AL Frelinger III JE Zull 1984 Oxidized forms of parathyroid hormone with biological activity J Bio Chem 259 5507 5513 1:CAS:528:DyaL2cXktVSqtr4%3D
21. AL Frelinger III JE Zull 1986 The role of the methionine residues in the structure and function of parathyroid hormone Arch Biochem Biophy 244 641 649 10.1016/0003-9861(86)90632-6 1:CAS:528:DyaL28Xot1Wktw%3D%3D
22. JE Zull SK Smith R Wiltshire 1990 Effect of methionine oxidation and deletion of amino-terminal residues on the conformation of parathyroid hormone-circular dichroism studies J Bio Chem 265 5671 5676 1:CAS:528: DyaK3cXktFOqtLs%3D